Categories Other Industries

New flu vaccine brings Novavax back to life

Novavax shares skyrocketed after the company’s latest study into its flu vaccine offered promising results. The company’s vaccine for flu, NanoFlu, generated stronger results when compared to the standard vaccines that are currently available.

The Gaithersburg, Maryland-based company had a tumultuous journey throughout 2017 after it witnessed a dramatic failure of its closely watched vaccine for respiratory infection. Though the company officials were quite confident about its success, investors started losing faith in this stock over rising concerns of its sustainability. This soon led way to takeover rumors.

Picture for representation

NanoFlu has now forced investors to change their opinion about this company.

Novavax claims that NanoFlu was almost 47-64% more effective against different strains of the nastiest H3N2, when compared to the standard flu vaccines.

Rivals Sanofi and GlaxoSmithKline have already developed their own flu vaccines and have started marketing them. However, Novavax claims that NanoFlu was almost 47-64% more effective against different strains of the nastiest H3N2, when compared to the standard flu vaccines. This marks a big achievement for Novavax, because several articles from various medical journals have highlighted how the other vaccines have been less effective against the swine flu virus.

If NanoFlu hits the right targets, investors may eventually see buyout rumors fading. The company plans to kick-start its Phase 2 trial for NanoFlu vaccine during the third quarter of this year.

Most Popular

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain

eBay (EBAY): A few factors that helped drive growth in Q3 2024

Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top